Low PS - Search Results

1

An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas.

Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S. Predina JD, et al. Among authors: low ps. Oncotarget. 2018 Feb 5;9(17):13517-13529. doi: 10.18632/oncotarget.24399. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568374 Free PMC article.

2

Synthesis and activity of a folate peptide camptothecin prodrug.

Henne WA, Doorneweerd DD, Hilgenbrink AR, Kularatne SA, Low PS. Henne WA, et al. Among authors: low ps. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5350-5. doi: 10.1016/j.bmcl.2006.07.076. Epub 2006 Aug 9. Bioorg Med Chem Lett. 2006. PMID: 16901694

3

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.

He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, Low PS. He W, et al. Among authors: low ps. Int J Cancer. 2008 Oct 15;123(8):1968-73. doi: 10.1002/ijc.23717. Int J Cancer. 2008. PMID: 18661519 Free PMC article.

4

Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents.

Kularatne SA, Zhou Z, Yang J, Post CB, Low PS. Kularatne SA, et al. Among authors: low ps. Mol Pharm. 2009 May-Jun;6(3):790-800. doi: 10.1021/mp9000712. Mol Pharm. 2009. PMID: 19361232 Free PMC article.

5

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand.

Kularatne SA, Wang K, Santhapuram HK, Low PS. Kularatne SA, et al. Among authors: low ps. Mol Pharm. 2009 May-Jun;6(3):780-9. doi: 10.1021/mp900069d. Mol Pharm. 2009. PMID: 19361233

6

Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies.

Yi YS, Ayala-López W, Kularatne SA, Low PS. Yi YS, et al. Among authors: low ps. Mol Pharm. 2009 Jul-Aug;6(4):1228-36. doi: 10.1021/mp900070b. Mol Pharm. 2009. PMID: 19374407

7

Folate-targeted therapeutic and imaging agents for cancer.

Low PS, Kularatne SA. Low PS, et al. Curr Opin Chem Biol. 2009 Jun;13(3):256-62. doi: 10.1016/j.cbpa.2009.03.022. Epub 2009 May 4. Curr Opin Chem Biol. 2009. PMID: 19419901 Review.

8

Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues.

Thomas M, Kularatne SA, Qi L, Kleindl P, Leamon CP, Hansen MJ, Low PS. Thomas M, et al. Among authors: low ps. Ann N Y Acad Sci. 2009 Sep;1175:32-9. doi: 10.1111/j.1749-6632.2009.04977.x. Ann N Y Acad Sci. 2009. PMID: 19796075

9

Targeting of nanoparticles: folate receptor.

Kularatne SA, Low PS. Kularatne SA, et al. Among authors: low ps. Methods Mol Biol. 2010;624:249-65. doi: 10.1007/978-1-60761-609-2_17. Methods Mol Biol. 2010. PMID: 20217601

10

Deep-tissue imaging of intramolecular fluorescence resonance energy-transfer parameters.

Gaind V, Kularatne S, Low PS, Webb KJ. Gaind V, et al. Among authors: low ps. Opt Lett. 2010 May 1;35(9):1314-6. doi: 10.1364/OL.35.001314. Opt Lett. 2010. PMID: 20436553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters